Icl Israel Chemicals Stock Filter Stocks by Fundamentals
| ICL Stock | USD 4.63 0.08 1.70% |
ICL Israel Chemicals fundamentals help investors to digest information that contributes to ICL Israel's financial success or failures. It also enables traders to predict the movement of ICL Stock. The fundamental analysis module provides a way to measure ICL Israel's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ICL Israel stock.
ICL | Shares Owned by Institutions |
ICL Israel ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, ICL Israel's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ICL Israel's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
ICL Israel Institutional Holders
Institutional Holdings refers to the ownership stake in ICL Israel that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ICL Israel's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ICL Israel's value.| Shares | Yousif Capital Management, Llc | 2023-09-30 | 0.0 | Sumitomo Mitsui Trust Holdings Inc | 2024-03-31 | 0.0 | Zb,n.a. | 2023-12-31 | 0.0 | Clal Insurance Enterprises Holdings Ltd | 2023-12-31 | 522.1 K | V-square Quantitative Management | 2023-12-31 | 80.5 K | Northern Trust Corp | 2023-12-31 | 36.1 K | Ubs Asset Mgmt Americas Inc | 2023-12-31 | 17.3 K | Ameriprise Financial Inc | 2023-12-31 | 13.9 K | Ifp Advisors, Llc | 2023-12-31 | 5.2 K | Rfp Financial Group Llc | 2023-12-31 | 614 | Arlington Trust Co Llc | 2023-12-31 | 233 |
ICL Fundamentals
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0603 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 8.45 B | ||||
| Shares Outstanding | 1.29 B | ||||
| Shares Owned By Insiders | 44.06 % | ||||
| Shares Owned By Institutions | 23.45 % | ||||
| Number Of Shares Shorted | 1.21 M | ||||
| Price To Earning | 918.89 X | ||||
| Price To Book | 1.06 X | ||||
| Price To Sales | 0.83 X | ||||
| Revenue | 7.65 B | ||||
| Gross Profit | 5.03 B | ||||
| EBITDA | 1.81 B | ||||
| Net Income | 657.17 M | ||||
| Cash And Equivalents | 516 M | ||||
| Cash Per Share | 0.40 X | ||||
| Total Debt | 2.66 B | ||||
| Debt To Equity | 0.51 % | ||||
| Current Ratio | 1.65 X | ||||
| Book Value Per Share | 4.47 X | ||||
| Cash Flow From Operations | 1.62 B | ||||
| Short Ratio | 1.48 X | ||||
| Earnings Per Share | 0.50 X | ||||
| Price To Earnings To Growth | 9.44 X | ||||
| Target Price | 5.3 | ||||
| Number Of Employees | 12.55 K | ||||
| Beta | 0.59 | ||||
| Market Capitalization | 6.07 B | ||||
| Total Asset | 11.53 B | ||||
| Retained Earnings | 5.54 B | ||||
| Working Capital | 1.4 B | ||||
| Current Asset | 2.98 B | ||||
| Current Liabilities | 2.05 B | ||||
| Annual Yield | 0.04 % | ||||
| Five Year Return | 3.55 % | ||||
| Net Asset | 11.53 B | ||||
| Last Dividend Paid | 0.28 |
About ICL Israel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ICL Israel Chemicals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICL Israel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICL Israel Chemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out ICL Israel Piotroski F Score and ICL Israel Altman Z Score analysis. Note that the ICL Israel Chemicals information on this page should be used as a complementary analysis to other ICL Israel's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for ICL Stock analysis
When running ICL Israel's price analysis, check to measure ICL Israel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICL Israel is operating at the current time. Most of ICL Israel's value examination focuses on studying past and present price action to predict the probability of ICL Israel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICL Israel's price. Additionally, you may evaluate how the addition of ICL Israel to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is ICL Israel's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Dividend Share 0.277 | Earnings Share 0.5 | Revenue Per Share 5.845 | Quarterly Revenue Growth (0.19) |
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.